PA
JD icon

PharVision Advisers’s JD.com JD Stock Holding History

PharVision Advisers’s Portfolio JD Stock Details JD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,081
Closed -$248K – 849
2025
Q3 		$248K Buy
+7,081
New +$231K 0.14% 341

Other funds holding JD

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DG
Discerene Group Stamford, Connecticut $946M AUM 1.38% 1-Year Est. Return
CCM
CoreView Capital Management Hong Kong $473M AUM 14.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's JD Position: Q4 2025 in Review

PharVision Advisers sold out of JD.com (JD) in Q4 2025, closing a stake of 7,081 shares — an estimated $248K sold.

PharVision Advisers first reported a position in JD in Q3 2025 and held it in 1 quarter. The position peaked at $248K in Q3 2025. 438 funds tracked by Wall St. Rank hold JD as of Q4 2025.

  • PharVision Advisers reported no remaining JD.com position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 7,081 JD.com shares in Q4 2025, an estimated $248K.
  • PharVision Advisers first reported a position in JD.com in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's JD.com position peaked at $248K in Q3 2025.
  • 438 funds tracked by Wall St. Rank held JD.com as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.